A positive correlation has been observed between IL-6 levels and body mass index (BMI), and increasing soluble IL-6 receptor alpha (sIL-6Rα) and gp130/sIL-6Rβ levels has been shown to alleviate NAFLD in obesity [140]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.